Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2582-2585

  Olsen, Keith M ^a,b   San Pedro, Gerardo S ^c   Gann, Larry P ^c   Gubbins, Paul O ^c   Halinski, David M ^c   Campbell Jr , G Douglas ^d  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ADULT; ARTICLE; CHRONIC BRONCHITIS; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TISSUE LEVEL; HUMAN; HUMAN EXPERIMENT; LUNG INFECTION; MINIMUM INHIBITORY CONCENTRATION; MONOCYTE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL;

EID: 0029958622     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2582     Document Type: Article

References (24)

1. Anderson, R., G. Joone, and C. E. J. van Rensburg. 1988. An in-vitro evaluation of the cellular uptake and imraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent. J. Antimicrob. Chemother. 22:923-933.
2. Baldwin, D, R., D. Honeybourne, and R. Wise. 1992. Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob. Agents Chemother. 36:1171-1175.
3. Baldwin, D. R., D. Honeybourne, and R. Wise. 1992. Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance. Antimicrob. Agents Chemother. 36:1176-1180.
4. Baldwin, D. R., R. Wise, J. M. Andrews, J. P. Ashby, and D. Honeybourne. 1990. Azithromycin concentrations at the sites of pulmonary infection. Eur. Respir. J. 3:886-890.
5. Bonnet, M., and P. Van der Auwera. 1992. In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62,993) and its influence on ex vivo leukocyte chemiluminescence. Antimicrob. Agents Chemother. 36:1302-1309.
6. Conte, J. E., Jr., J. A. Golden, S. Duncan, E. McKenna, and E. Zurlinden. 1995. Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin. Antimicrob. Agents Chemother. 39:334-338.
7. Crapo, J. D., B. E. Barry, R. Behr, M. Bachofen, and E. R. Weibel. 1982. Cell numbers and cell characteristics of the normal human lung. Am. Rev. Respir. Dis. 126:332-337.
8. Felmingham, D., M. J. Robbins, M. Sanghrajka, A. Leakey, and G. L. Ridgway. 1991. The in vitro activity of some 14-, 15- and 16-membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum. Drugs Exp. Clin. Res. 17:91-99.
9. Foulds, G., and R. B. Johnson. 1993. Selection of dose regimens of azithromycin. J. Antimicrob. Chemother. 31(Suppl. E):39-50.
10. Foulds, G., R. M. Shepard, and R. B. Johnson. 1990. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25(Suppl. A):73-82.
11. Gladue, R. P., G. M. Bright, R. E. Isaacson, and M. F. Newborg. 1989. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob. Agents Chemother. 33:277-282.
12. Hardy, D. J., D. M. Hensey, J. M. Beyer, C. Vojtko, E. J. McDonald, and P. B. Fernandes. 1988. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob. Agents Chemother. 32:1710-1719.
13. Johnson, J. D., W. L. Hand, J. B. Francis, N. King-Thompson, and R. W. Corwin. 1980. Antibiotic uptake by alveolar macrophages. J. Lab. Clin. Med. 95:429-439.
14. Lode, H. 1991. The pharmacokinetics of azithromycin and their clinical significance. Eur. J. Clin. Microbiol. Infect. Dis. 10:807-812.
15. McDonald, P. J., and H. Pruul. 1991. Phagocyte uptake and transport of azithromycin. Eur. J. Clin. Microbiol. Infect. Dis. 10:828-833.
16. Meyer, A. P., C. Bril-Bazuin, H. Mattie, and P. J. van den Broek. 1993. Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus. Antimicrob. Agents Chemother. 37:2318-2322.
17. Rennard, S. I., G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532-538.
18. Retsema, J., A. Girard, W. Schelkly, M. Manousos, M. Anderson, G. Bright, R. Borovoy, L. Brennan, and R. Mason. 1987. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob. Agents Chemother. 31:1939-1947.
19. Retsema, J. A., A. E. Girard, D. Girard, and W. B. Milisen. 1990. Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo. J. Antimicrob. Chemother. 25(Suppl. A):83-89.
20. Schentag, J. J., and C. H. Ballow. 1991. Tissue-directed pharmacokinetics. Am. J. Med. 91(Suppl. 3A):5S-11S.
21. Shepard, R. M., G. S. Duthu, R. A. Ferraina, and M. A. Mullins. 1994. High-performance liquid chromatographic assay with electrochemical detection for azithromycin in serum and tissues. J. Chromatogr. 565:321-337.
22. Vallée, É., E. Azoulay-Dupuis, J.-J. Pocidalo, and E. Bergogne-Bérézin. 1992. Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection. Antimicrob. Agents Chemother. 36:1412-1417.
23. Wildfeuer, A., H. Laufen, and T. Zimmermann. 1994. Distribution of orally administered azithromycin in various blood compartments. Int. J. Clin. Pharmacol. Ther. 32:356-360.
24. Wildfeuer, A., I. Reisert, and H. Laufen. 1993. Uptake and subcellular distribution of azithromycin in human phagocytic cells: demonstration of the antibiotic in neutrophil polymorphonuclear leucocytes and monocytes by autoradiography and electron microscopy. Arzneim.-Forsch. 43:484-486.